Drug and Therapeutics Bulletin 1997;35:84-86; doi:10.1136/dtb.1997.351184
Copyright © 1997 by the BMJ Publishing Group Ltd.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Combined hepatitis A and B vaccines

Relevant BNF section: 14.4

Within the last decade, the development of effective monovalent vaccines has provided a major advance in the prevention of both hepatitis A and B. We have previously reviewed these vaccines.1,2 Now, combined (bivalent) hepatitis A and B vaccines have been licensed ({blacktriangledown}Twinrix Adult and {blacktriangledown}Twinrix Paediatric-SmithKline Beecham). Here we consider the potential uses for such combined vaccines.






About DTB - Privacy policy - Terms and conditions relating to subscriptions purchased online - Web site terms and conditions - Feedback

© 1997 BMJ Publishing Group Ltd.